Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:96-103

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, C.-s.
Right arrow Articles by Qin, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, C.-s.
Right arrow Articles by Qin, F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
Hazardous Substances DB
*ASCORBIC ACID
*SODIUM ASCORBATE
*VITAMIN A
Related Collections
Right arrow Heart failure - basic studies
Right arrow Oxidant stress

(Circulation. 2000;102:96.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Alterations by Norepinephrine of Cardiac Sympathetic Nerve Terminal Function and Myocardial ß-Adrenergic Receptor Sensitivity in the Ferret

Normalization by Antioxidant Vitamins

Presented in part at the 46th Annual Scientific Sessions of the American College of Cardiology, Anaheim, Calif, March 19, 1997, and the 71st Scientific Sessions of the American Heart Association, Dallas, Tex, November 11, 1998, and published in abstract form (J Am Coll Cardiol. 1997;29[suppl]:500A; Circulation. 1998;98[suppl I]:I-650).

Chang-seng Liang, MD, PhD; Naomi Kenmotsu Rounds, MD; Erdan Dong, MD, PhD; Suzanne Y. Stevens, PhD; Junya Shite, MD; Fuzhong Qin, MD

From the Cardiology Unit, Department of Medicine, and Department of Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, NY.

Correspondence to Chang-seng Liang, MD, PhD, Cardiology Unit, Box 679, University of Rochester Medical Center, 601 Elmwood Ave, Box 679, Rochester, NY 14642-8679. E-mail chang-seng_liang{at}urmc.rochester.edu

Background—Chronic excessive norepinephrine (NE) causes cardiac sympathetic nerve terminal abnormalities, myocardial ß-adrenergic receptor downregulation, and ß-adrenergic subsensitivity. The present study was carried out to determine whether these changes could be prevented by antioxidants.

Methods and Results—Ferrets were administered either NE (1.33 mg/d) or vehicle by use of subcutaneous pellets for 4 weeks. Animals were simultaneously assigned to receive either antioxidant vitamins (ß-carotene, ascorbic acid, and {alpha}-tocopherol) or placebo pellets. NE increased plasma NE 4- to 5-fold but had no effect on heart rate, heart weight, arterial pressure, or left ventricular systolic function. However, myocardial NE uptake activity and NE uptake-1 site density were reduced, as well as cardiac neuronal NE, tyrosine hydroxylase, and neuropeptide Y. In addition, there was a decrease in myocardial ß-adrenergic receptor density with a selective decrease of the ß1-receptor subtype, reduction of the high-affinity site for isoproterenol, decreased basal adenylyl cyclase activity, and the adenylyl cyclase responses to isoproterenol, Gpp(NH)p, and forskolin. All of these changes were prevented by antioxidant vitamins. The effects of NE on myocardial ß-adrenergic receptor density, NE uptake-1 carrier site density, and neuronal NE were also prevented by superoxide dismutase or Trolox C.

Conclusions—The toxic effects of NE on the sympathetic nerve terminals are mediated via the formation of NE-derived oxygen free radicals. Preservation of the neuronal NE reuptake mechanism is functionally important, because the antioxidants also prevented myocardial ß-adrenergic receptor downregulation and postreceptor abnormalities. Thus, antioxidant therapy may be beneficial in heart failure, in which cardiac NE release is increased.


Key Words: norepinephrine • antioxidants • receptors, adrenergic, beta • heart failure




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
R. Sethi, A. Adameova, K. S. Dhalla, M. Khan, V. Elimban, and N. S. Dhalla
Modification of Epinephrine-induced Arrhythmias by N-Acetyl-L-Cysteine and Vitamin E
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 134 - 142.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-s. Liang, W. Mao, C. Iwai, S. Fukuoka, and S. Y. Stevens
Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H995 - H1003.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Cohen-Solal, F. Rouzet, A. Berdeaux, D. Le Guludec, E. Abergel, A. Syrota, and P. Merlet
Effects of Carvedilol on Myocardial Sympathetic Innervation in Patients with Chronic Heart Failure
J. Nucl. Med., November 1, 2005; 46(11): 1796 - 1803.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Mao, C. Iwai, F. Qin, and C.-s. Liang
Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2381 - H2389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.-s. Liang
Importance of antioxidant and antiapoptotic effects of {beta}-receptor blockers in heart failure therapy
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1003 - H1012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Mao, F. Qin, C. Iwai, R. Vulapalli, P. C. Keng, and C.-s. Liang
Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H29 - H39.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B.-i. Kato, T. Nozawa, N. Igarashi, M. Nonomura, N. Fujii, A. Igawa, H. Asanoi, Y. Yamada, M. Inoue, and H. Inoue
Discrepant Recovery Course of Sympathetic Neuronal Function and {beta}-Adrenoceptors in Rat Hearts After Reperfusion Following Transient Ischemia
J. Nucl. Med., June 1, 2004; 45(6): 1074 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mak and G. E. Newton
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H789 - H795.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Canty Jr and J. A. Fallavollita
Sympathetic Nerves and Myocyte Necrosis: More Than Meets the Eye
Circ. Res., October 31, 2003; 93(9): 796 - 798.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Moritz, C. Monteil, M. Isabelle, F. Bauer, S. Renet, P. Mulder, V. Richard, and C. Thuillez
Role of reactive oxygen species in cocaine-induced cardiac dysfunction
Cardiovasc Res, October 1, 2003; 59(4): 834 - 843.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Qin, J. Shite, and C.-s. Liang
Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-s. Liang, A. Yatani, Y. Himura, M. Kashiki, and S. Y. Stevens
Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1729 - H1736.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-S. Liang, Y. Himura, M. Kashiki, and S. Y. Stevens
Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1863 - H1872.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. Merlet, L. Hittinger, J. L. Dubois-Rande, and A. Castaigne
Myocardial Adrenergic Dysinnervation in Dilated Cardiomyopathy: Cornerstone or Epiphenomenon?
J. Nucl. Med., April 1, 2002; 43(4): 536 - 539.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. T. Sia, T. G. Parker, P. Liu, J. N. Tsoporis, A. Adam, and J. L. Rouleau
Improved post-myocardial infarction survival with probucol in rats: Effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression
J. Am. Coll. Cardiol., January 2, 2002; 39(1): 148 - 156.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn
Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action
Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Shite, F. Qin, W. Mao, H. Kawai, S. Y. Stevens, and C.-s. Liang
Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy
J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1734 - 1740.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Qin, N. K. Rounds, W. Mao, K. Kawai, and C.-s. Liang
Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets
Cardiovasc Res, September 1, 2001; 51(4): 736 - 748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kawai, S. Y. Stevens, and C.-S. Liang
Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Qin, R. S. Vulapalli, S. Y. Stevens, and C.-S. Liang
Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H363 - H371.
[Abstract] [Full Text] [PDF]